SCHEMBL13618119

SCHEMBL13618119

COCCOC(C)C(OCCOC)OCCOC

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13609147 0.80 PIK3CD (0.32) PIK3CD
SCHEMBL18775404 0.78 PIK3CD (0.31) PIK3CD
SCHEMBL13618127 0.77
SCHEMBL13618116 0.77
SCHEMBL13618129 0.77
SCHEMBL18401270 0.76 DDAH1 (0.30) PIK3CD
SCHEMBL1250515 0.74 CA2 (0.32)
SCHEMBL47033 0.73
SCHEMBL891898 0.73 LMNA (0.42) PIK3CD
SCHEMBL28164439 0.73 PIK3CD (0.35) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090276965-A1 Glyoxal-alkyl polyglycol ether acetals CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090276965-A1 Glyoxal-alkyl polyglycol ether acetals ABHD6, C9, ABHD5 PIK3CD 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.